LOC100293211: A Drug Target / Disease Biomarker (G100293211)
LOC100293211: A Drug Target / Disease Biomarker
LOC100293211 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoplasmic proteins, which are a type of protein that is found in all eukaryotic cells.
LOC100293211 is unique because of its structure and the way it is expressed in different tissues. It is made up of 254 amino acids and has a calculated molecular mass of 33.9 kDa. It is also known as OLVL1 because it contains a single transmembrane region and a cytoplasmic tail.
One of the things that makes LOC100293211 so interesting as a drug target is its location in the brain. The brain is a highly evolved organ that is responsible for controlling everything from thought and emotion to movement and behavior. As a result, LOC100293211 is a perfect candidate for drug development because it is assumed to play a role in brain function.
In addition to its location in the brain, LOC100293211 is also known for its role in the development and progression of various diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It is also involved in the development of certain cancers, such as neuroblastoma.
Another way that LOC100293211 is being targeted for drug development is its expression in certain diseases. For example, studies have shown that LOC100293211 is expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the development of certain neurological symptoms in these individuals. This suggests that targeting LOC100293211 could be a promising strategy for the treatment of Alzheimer's disease.
Finally, LOC100293211 is also being targeted for drug development because of its unique structure and the way it is expressed in different tissues. Because it is a member of the cytoplasmic proteins, LOC100293211 is not typically targeted by small molecules, which are the most common type of drug used in clinical practice. However, because LOC100293211 is involved in so many different functions in the body, it is possible to develop new treatments that target it specifically.
In conclusion, LOC100293211 is a protein that is unique due to its structure and the way it is expressed in different tissues. It is a promising candidate for drug development due to its location in the brain and its involvement in the development and progression of various diseases. As research continues to develop, it is likely that LOC100293211 will become a valuable tool for the treatment of a wide range of conditions.
Protein Name: Uncharacterized LOC100293211
The "LOC100293211 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100293211 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164
